What's in a GENRE?
A new study from Jason Papin’s group at the University of Virginia’s Department of Biomedical Engineering published in Nature Communications describes the first genome-scale reconstruction (GENRE) of rat (iRno) and human (iHsa) metabolism. Their GENRE’s comprehensively map the metabolic differences between the species, such as their vitamin C and bile acid synthesis pathways.
Given that rats are used as human surrogate models to test hepatotoxicity in pre-clinical testing in pharma, understanding and predicting species-specific differences and similarities in drug metabolism between them and humans has cost, time and health benefits for drug development.
The authors integrated toxicogenomics microarray data from rat and human hepatocytes into their GENRE models as transcriptionally inferred metabolic biomarker responses (TIMBR).
They then ‘validated their predictions for xanthine derivatives with new experimental data and literature-based evidence delineating metabolite biomarkers unique to humans.’ (Blais et al. 2017)
Their study provides a systems-level overview of species-specific differences between rat and human metabolism captured with their in silico GENREs. This work highlights both the genomic similarities between humans and rats, but also reveals the metabolic pathway differences between the species which have been overlooked. This extra knowledge will aid preclinical development.
Written by Adam Tozer, Ph.D, Science Writer for www.TechnologyNetworks.com
Blais, E.M., Rawls, K.D., Dougherty, B.V., Li, Z.I., Kolling, G.L., Ye, P., Wallqvist, A. and Papin, J.A. (2017) ‘Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions’, Nature Communications, 8, p. 14250. doi: 10.1038/ncomms14250.
Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line TreatmentNews
The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.READ MORE
Diabetes Drug Could Be Re-purposed to Help End Transplant RejectionNews
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs.READ MORE
Revolutionary Imaging Technique Uses CRISPR to Map DNA MutationsNews
The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.READ MORE